SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
IMMX

Immix Biopharma, Inc. (IMMX)

NASDAQ: IMMX · USD
Healthcare · Biotechnology
$6.96-$0.08 (-1.14%)
 
Market cap
$583M
Insider Score
Analyst consensus
Insider Score
56/ 100
IMMX Insider Score
Bullish

2 qualifying trades · 2 insiders · $20.01K bought in the last 90 days

IMMX Income Statement

Fiscal PeriodQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Period EndingSep 30, 2026Jun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025
Revenue$0.00$0.00$0.00$0.00$0.00—
Revenue Growth (YoY)——————
Cost of Revenue——————
Gross Profit——————
SG&A Expense$10.40 M$7.12 M$4.82 M$5.17 M$3.08 M—
R&D Expense$5.54 M$5.33 M$5.98 M$5.73 M$4.58 M—
Operating Expenses$15.95 M$12.46 M$10.80 M$10.89 M$7.66 M—
Operating Income-$15.95 M-$12.46 M-$10.80 M-$10.89 M-$7.66 M—
Pretax Income-$13.93 M-$11.54 M-$10.09 M-$10.68 M-$7.58 M—
Tax Provision$0.00$14.32 K$0.00$11.27 K$7.72 K—
Net Income-$13.93 M-$11.56 M-$10.09 M-$10.69 M-$7.59 M—
EPS (Basic)-$0.19-$0.18-$0.18—-$0.24-$0.22
EPS (Diluted)-$0.19-$0.18-$0.18—-$0.24-$0.22
Shares Outstanding74.09 M63.77 M55.37 M—31.93 M29.98 M

Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
Immix Biopharma, Inc. (IMMX) Financials: Revenue, Earnings & Balance Sheet | InsiderBuying.com